NCT00115024View on ClinicalTrials.gov

EPAT: Estrogen in the Prevention of Atherosclerosis Trial

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

222

Participants

Timeline

Start Date

April 30, 1994

Primary Completion Date

November 30, 1998

Study Completion Date

November 30, 1998

Conditions
AtherosclerosisPostmenopause
Interventions
DRUG

Micronized 17B-estradiol

Trial Locations (1)

90033

Atherosclerosis Research Unit, Division of Cardiovascular Medicine, Department of Medicine, Los Angeles

All Listed Sponsors
collaborator

Mead Johnson Nutrition

INDUSTRY

lead

National Institute on Aging (NIA)

NIH